Neurology
RSSArticles
-
Bell's Palsy: Meta-analysis Supports Adding Anti-viral Medication to Steroid Therapy
Review of available literature suggests that combination therapy of Bell's palsy with both steroids and anti-virals results in the best outcome. -
New Genetic Clues to Alzheimer's Disease Risk
Recent breakthroughs in genetic research will bring us closer to being able to diagnose an individual's risk of developing late-onset sporadic Alzheimer's disease. -
Diagnostic Utility of Muscle Biopsies in the Age of Molecular Genetics
Muscle biopsy still remains an important test for determining correct diagnosis and treatment of patients with suspected muscle disease. -
Primary Care Reports - Full November 1, 2009 Issue in PDF
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Depression and pregnancy, new vaccine recommendations from the CDC, cortico-steroids and/or antivirals for Bell's palsy, rasagiline and Parkinson's disease, and FDA Actions. -
Neurology Alert - Full November 1, 2009 Issue in PDF
-
A 2nd-generation Anti-epileptic Agent for Childhood Occipital Epilepsy
This open label trial reports on the long-term efficacy and tolerability of levetiracetam in children with late onset childhood occipital epilepsy. -
Hospital Medicine Alert - Full November 1, 2009 Issue in PDF
-
Alternative Dosing of Oseltamivir for Specific Patient Populations: Critically Ill and Renally Impaired
Oseltamivir (Tamiflu®) is an FDA-approved drug for the treatment and prevention of influenza. With the anticipated emergence of seasonal influenza virus cases in October, and the recent discoveries of novel H5N1 (avian) and 2009 H1N1 (swine) influenza viruses, it is imperative to understand how to appropriately dose oseltamivir.